Recommendations for public health programs on the use of pneumococcal vaccines in children, including the use of 15-valent and 20-valent conjugate vaccines : economic evidence supplementary appendix.: HP5-239/3-2024E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.934200&sl=0
| Department/Agency | Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. |
|---|---|
| Title | Recommendations for public health programs on the use of pneumococcal vaccines in children, including the use of 15-valent and 20-valent conjugate vaccines : economic evidence supplementary appendix. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Cover title. Issued also in French under title: Recommandations pour les programmes de santé publique sur l'utilisation des vaccins contre le pneumocoque chez les enfants, y compris l'utilisation des vaccins conjugués 15-valent et 20-valent : annexe complémentaire sur les données probantes économiques. At head of title: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). "Pub.: 230769." Includes bibliographical references (pages 50-56). |
| Publishing information | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, March 2024. ©2024 |
| Description | 1 online resource (56 pages) : illustrations |
| ISBN | 9780660703923 |
| Catalogue number |
|
| Subject terms | Vaccination -- Economic aspects -- Canada. Vaccination of children -- Canada. Pneumococcal vaccine -- Canada. Streptococcus pneumoniae -- Vaccination -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: